{"id":28431,"date":"2020-07-14T05:55:00","date_gmt":"2020-07-14T05:55:00","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=28431"},"modified":"2020-07-14T05:55:00","modified_gmt":"2020-07-14T05:55:00","slug":"norepinephrine-reuptake-inhibitors-nris","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/","title":{"rendered":"Norepinephrine reuptake inhibitors (NRIs)"},"content":{"rendered":"<p>A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-28431","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)<\/title>\n<meta name=\"description\" content=\"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)\" \/>\n<meta property=\"og:description\" content=\"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-14T05:55:00+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/\",\"name\":\"Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-14T05:55:00+00:00\",\"dateModified\":\"2020-07-14T05:55:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Norepinephrine reuptake inhibitors (NRIs)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)","description":"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/","og_locale":"en_US","og_type":"article","og_title":"Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)","og_description":"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/","og_site_name":"Glossary","article_published_time":"2020-07-14T05:55:00+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/","name":"Norepinephrine reuptake inhibitors (NRIs) - Definition of Norepinephrine reuptake inhibitors (NRIs)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-14T05:55:00+00:00","dateModified":"2020-07-14T05:55:00+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A class of medications (also called selective norepinephrine reuptake inhibitors or norepinephrine specific reuptake inhibitors) that increase levels of the neurotransmitters norepinephrine and epinephrine by blocking the action of the norepinephrine transporter and hence the reuptake of neurotransmitters back into neurons. NRIs may be used in the clinical treatment of attention-deficit\/hyperactivity disorder (ADHD) and narcolepsy (e.g., atomoxetine [strattera]) as well as mood disorders such as major depressive disorder (e.g., the tetracyclic agent maprotiline [ludiomil]).","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-reuptake-inhibitors-nris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Norepinephrine reuptake inhibitors (NRIs)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=28431"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28431\/revisions"}],"predecessor-version":[{"id":28432,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28431\/revisions\/28432"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=28431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=28431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=28431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}